HQ-NOM 200mg- (Hydroxychloroquine)

What is HQ-NOM 200mg- (Hydroxychloroquine)?

HQ-NOM 200mg- (Hydroxychloroquine) is a disease-modifying antirheumatic drug (DMARD) prescribed to treat chronic autoimmune disorders, including rheumatoid arthritis and systemic lupus erythematosus (SLE). It works by reducing immune system overactivity, helping to control symptoms such as joint pain, swelling, and skin rashes. Though not a cure, it can slow disease progression and improve daily function. It may also be used off-label to support glycemic control in type 2 diabetes, though this is not its primary indication.

Key features

• Active ingredient — Hydroxychloroquine sulfate 200mg per tablet.
• Therapeutic class — DMARD for autoimmune disease management.
• Dosing flexibility — Typically taken once or twice daily based on condition.
• Long-term use — Suitable for maintenance therapy in chronic conditions.
• Oral administration — Convenient tablet form for daily use.
• Prescription required — Not available over-the-counter.
• Manufactured to standards — Sourced from verified pharmaceutical suppliers.

Who is HQ-NOM 200mg- (Hydroxychloroquine) for?

This medication is intended for adults diagnosed with autoimmune disorders such as rheumatoid arthritis or lupus. It is best suited for patients under ongoing medical supervision due to potential side effects, including retinal toxicity with long-term use. It is not intended for acute pain relief but rather for sustained immune regulation.

How does HQ-NOM 200mg- (Hydroxychloroquine) compare?

Compared to NSAIDs, hydroxychloroquine offers disease-modifying effects rather than just symptom relief. Unlike biologic DMARDs, it is oral, lower-cost, and widely accessible but may take weeks to show full effect. It is often used in combination therapy and is less potent than immunosuppressants like methotrexate but has a more favorable safety profile for some patients.